home

Breaking News

Redox Pharmaceutical Corporation announced the granting of a new United States patent on the use of CTC-96 (Doxovir™) for the Treatment of Psoriasis.

Redox Pharmaceutical Corporation has successfully completed Phase IB and Phase II Clinical Trials for Herpes Labialis (cold sores).


©2011 Redox Pharmaceutical Corporation.
All rights reserved.

Send us your site suggestions & service requests.

Site hosted by: Transbeam.com
Non-Steroidal Anti-Inflammatory
Non-Steroidal Anti-Inflammatory
Redox’s family of cobalt Schiff base chelates were initially designed and developed for their capacity to scavenge superoxide radicals. Our drugs possess anti-inflammatory properties by virtue of this property. This activity promotes and enhances recovery of virus-damaged tissues. Further studies are planned for exploring this application in various systems.
Contact Us | Home

MEDICAL APPLICATIONS

Ocular Applications Adenovirus-derived Keratoconjunctivitis Herpetic Keratitis

Dermal Application
Facial Herpes

Anti-Inflammatory Application
Non-Steroidal anti-inflammatory